Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
ResMed Inc. announced a change in beneficial ownership involving Peter C. Farrell, a director and significant shareholder of the company. Farrell acquired 536 shares of ResMed common stock, which were awarded as Restricted Stock Units (RSUs) that will vest in full by November 2026 or at the next annual stockholders’ meeting. This transaction reflects ongoing changes in the company’s ownership structure, potentially impacting shareholder dynamics and corporate governance.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$42.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Average Trading Volume: 1,214,271
Technical Sentiment Signal: Buy
Current Market Cap: A$56.69B
Find detailed analytics on RMD stock on TipRanks’ Stock Analysis page.